Concepedia

Author

P. van Heerde

The Netherlands Cancer Institute

Also Known As

P Van Heerde, P v Heerde, P van Heerde, P. VAN HEERDE, P. Van Heerde, P. van Heerde, P.van Heerde, Peter Heerde, Peter Van Heerde, Peter van Heerde

74

Publications

4.4K

Citations

37

H-Index

65

Concepts

All Affiliations

The Netherlands Cancer InstituteUniversity of AmsterdamUtrecht UniversityOncode InstituteAmsterdam UMC Location University of Amsterdam
PV

About

P. van Heerde is an author at The Netherlands Cancer Institute specializing in medicine, pathology, and histopathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

29

1.8K

2

Health Sciences

5

5

268

3

Engineering

2

2

32

4

Biomedical Engineering

2

2

32

5

Public Health

1

1

150

P. van Heerde

×

50

Publications

3.9K

Citations

33

H-Index

YearCitations

Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

Flora E. van Leeuwen, Willem J. Klokman, Anton Hagenbeek,

Journal of Clinical Oncology

1994

447

Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood

Flora E. van Leeuwen, Willem J. Klokman, Mars B. vanʼt Veer,

Journal of Clinical Oncology

2000

437

Prognostic factors for the treatment of malignant lymphoma in dogs

Erik Teske, P. van Heerde, Gerard R. Rutteman,

Journal of Small Animal Practice

1995

207

Prognostic factors for treatment of malignant lymphoma in dogs

Erik Teske, P. van Heerde, Gerard R. Rutteman,

Journal of the American Veterinary Medical Association

1994

190

Histological grading in gastric lymphoma: Pretreatment criteria and clinical relevance

Daphne de Jong, Henk Boot, P. van Heerde,

Gastroenterology

1997

172

Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T‐cell or null cell phenotype

Peter C. de Bruin, Rob C. Beljaards, P. van Heerde,

Histopathology

1993

166

Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept.

Babs G. Taal, Henk Boot, P. van Heerde,

Gut

1996

157

Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.

Flora E. van Leeuwen, R. Somers, B.G. Taal,

Journal of Clinical Oncology

1989

150

Activated Cytotoxic T Cells as Prognostic Marker in Hodgkin's Disease

J J Oudejans, Natasha Jiwa, J. Alain Kummer,

Blood

1997

136

Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma

B.W. Ongerboer de Visser, R. Somers, Willem H. Nooyen,

Neurology

1983

128

Page 1